All results

1 results for open label extension study evaluate safety usl255 adjunctive therapy patients

• HBS-101-CL-002

  The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS)…

  Ages

  6 Years - 65 Years

  Sexes

  All